Sign in to continue:

Wednesday, March 4th, 2026

Prudential plc Share Buyback and Issued Shares Update – March 2026 Disclosure Return

Prudential plc Announces Share Repurchases and Changes to Issued Share Capital

Prudential plc has released its latest Next Day Disclosure Return, detailing significant share repurchase activities and changes to its issued share capital as of early March 2026. The company’s actions come under the disclosure requirements of the Hong Kong Stock Exchange and are important developments for shareholders and potential investors.

Key Points from the Disclosure Report

  • Repurchase and Cancellation of Shares:
    Prudential repurchased 304,099 ordinary shares on 27 February 2026, which were subsequently cancelled on 3 March 2026 at a volume-weighted average price of GBP 11.3771 per share. This represents a reduction of approximately 0.01199% of the company’s issued share capital.
  • Ongoing Repurchases Pending Cancellation:
    As of 2 and 3 March 2026, Prudential had also repurchased but not yet cancelled an additional 470,767 shares (at GBP 11.0836 per share) and 460,449 shares (at GBP 10.7145 per share), respectively. These pending cancellations represent further reductions of 0.018566% and 0.01816% in issued share capital, respectively.
  • Updated Share Capital:
    Following the latest cancellation, Prudential’s total number of issued ordinary shares now stands at 2,535,275,900 (excluding treasury shares).
  • Significant Repurchase Activity:
    On 3 March 2026, Prudential repurchased 460,449 shares on the London Stock Exchange at prices ranging from GBP 10.54 to GBP 10.84, for a total aggregate price of GBP 4,933,487.38.
  • Repurchase Mandate:
    The current repurchase mandate, granted on 14 May 2025, authorizes the company to buy back up to 262,668,701 shares. To date, the company has repurchased a total of 72,096,809 shares under this mandate, representing approximately 2.77% of the issued share capital as of the mandate date.
  • Moratorium on New Share Issues:
    Prudential is subject to a moratorium period, meaning it cannot issue new shares or sell/transfer treasury shares until 2 April 2026, unless prior approval is obtained from the Exchange.

Important Information for Shareholders

  • Potential Price Sensitivity:
    The ongoing share buyback programme is a key signal of management’s confidence in the company’s value. Share repurchases reduce the total number of shares outstanding, potentially increasing earnings per share and supporting the share price.
  • Volume and Price Impact:
    The repurchases have been executed at prices between GBP 10.54 and GBP 11.38. The company’s willingness to buy back shares at these levels may indicate management’s view that the stock is undervalued at current prices.
  • Further Reductions to Share Capital:
    There are still over 900,000 shares repurchased and pending cancellation, which will further reduce the share count and may provide additional support to the share price in the near term.
  • Restriction on New Issuance:
    The temporary moratorium on new share issues or sales of treasury shares until April 2026 reduces the risk of immediate dilution for existing shareholders.

What Investors Should Watch

  • Track further announcements regarding the cancellation of pending repurchased shares, as this could further improve key per-share metrics.
  • Monitor the company’s buyback activity and the potential impact on liquidity and share price stability, especially in the context of Prudential’s ongoing capital management strategy.
  • The company’s continued use of its buyback mandate highlights strong capital discipline, which could be interpreted positively by the market.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should perform their own due diligence and consult with professional advisors before making any investment decisions. The information is based on the latest official disclosures by Prudential plc as of March 2026 and is subject to change.

View Prudential USD Historical chart here



Tianjin Pharmaceutical Da Ren Tang Group Receives Approval for Loxoprofen Sodium Cataplasms, Advancing Transdermal Drug Delivery in China

Highlights from the Announcement Drug Approval Details: The new product, Loxoprofen Sodium Cataplasms, is a gel-type patch indicated for the relief of inflammation and pain associated with osteoarthritis, muscle pain, and post-traumatic swelling and...

Keppel Infrastructure Trust 3Q 2025 Results & Global Marine Group Acquisition: Portfolio Growth, Financial Highlights, and Strategic Investment Updates

Keppel Infrastructure Trust (KIT) Q3 2025: Major Strategic Moves and Proposed Entry into Digital Infrastructure Keppel Infrastructure Trust (KIT) Q3 2025: Major Strategic Moves and Proposed Entry into Digital Infrastructure Executive Summary Keppel Infrastructure...

Rich Capital Holdings Completes 200-to-1 Share Consolidation and Announces New SGX-ST Stock Code

Rich Capital Holdings Completes 200-to-1 Share Consolidation Rich Capital Holdings Limited Completes 200-to-1 Share Consolidation Rich Capital Holdings Limited has announced the successful completion of its previously proposed share consolidation, with significant implications for...

   Ad